Company Filing History:
Years Active: 2020
Title: Manisha Bhutani: Innovator in Plasma Cell Disorder Research
Introduction
Manisha Bhutani is a prominent inventor based in Charlotte, NC, specializing in the field of plasma cell disorders. She has made significant contributions to medical research, particularly in understanding immunomodulatory derivatives and minimal residual disease in multiple myeloma patients. With a total of 2 patents, her work is paving the way for advancements in treatment methodologies.
Latest Patents
Manisha Bhutani's latest patents include innovative methods that address critical issues in plasma cell disorders. The first patent, titled "Methods of determining IMiDS resistance in plasma cell disorders," provides essential techniques for identifying resistance to immunomodulatory derivatives in affected individuals. The second patent, "Immune profiling and minimal residue disease following stem cell transplantation in multiple myeloma," outlines methods for assessing minimal residual disease in multiple myeloma patients. This patent emphasizes the importance of analyzing immune cell distribution and quantifying inflammatory markers to determine the patient's status effectively.
Career Highlights
Manisha Bhutani is currently associated with the Charlotte-Mecklenburg Hospital Authority, where she applies her expertise in medical research. Her work has garnered attention for its potential to improve patient outcomes in the field of hematology.
Collaborations
Manisha collaborates with esteemed colleagues such as Saad Z Usmani and Qing Zhang, contributing to a dynamic research environment focused on innovative solutions for complex medical challenges.
Conclusion
Manisha Bhutani's contributions to the field of plasma cell disorders through her patents and research are invaluable. Her work not only enhances our understanding of these conditions but also offers hope for improved treatment options for patients.